(E)-4-((4-((4-(2-Cyanovinyl)-2,6-dimethylphenyl)amino)pyrimidin-2-yl)amino)benzamide
- CAS
- 1446439-51-5
- Formula
- C22H20N6O
- MW
- 384.4 g/mol
VQ-027819
Product division
Impurities & Reference Standards
Pharmacopoeial and non-pharmacopoeial impurities, metabolites, nitrosamines and working standards with characterisation data for QC and regulatory work.
27,990products
6sub-categories
2,746in stock
COA + SDSwith every lot
API Impurities 14,098Pharmacopeial Impurities (EP / USP / BP) 4,399Nitrosamine Impurities 631Stable Isotope Labelled Standards (Deuterated, 13C, 15N) 1,504Metabolites & Degradation Products 3,922API Reference Standards 3,436
(E)-4-(1-(((4-Cyclohexyl-3-(trifluoromethyl)benzyl)oxy)imino) ethyl)-2-ethylbenzaldehyde
- CAS
- 1230487-01-0
- Formula
- C25H28F3NO2
- MW
- 431.5 g/mol
VQ-028045
(E)-4-(1-Benzyl-2-methyl-1H-imidazol-5-yl)-3-(ethoxycarbonyl)but-3-enoic Acid
- CAS
- 1640981-02-7
- Formula
- C18H20N2O4
- MW
- 328.4 g/mol
VQ-028229
(E)-4-(2-(2,5-Dioxopyrrolidin-1-yl)ethoxy)-4-oxobut-2-enoic acid
- CAS
- 2101811-41-8
- Formula
- C10H11NO6
- MW
- 241.2 g/mol
VQ-025349
(E)-5-((4-Carboxyphenyl)diazenyl)-2-hydroxybenzoic Acid
- CAS
- 1242567-07-2
- Formula
- C14H10N2O5
- MW
- 286.24 g/mol
VQ-034944
(E)-5-((4-Carboxyphenyl)diazenyl)-2-hydroxybenzoic Acid
- CAS
- 64896-26-0
- Formula
- C14H10N2O5
- MW
- 286.24 g/mol
VQ-035909
(E)-5-((Methylsulfinyl)methyl)-3-(((5-nitrofuran-2-yl)methylene)amino)oxazolidin-2-one
- CAS
- 1445990-09-9
- Formula
- C10H11N3O6S
- MW
- 301.28 g/mol
VQ-035094
(E)-5-(2-Bromovinyl)Pyrimidine-2,4(1H,3H)-dione
- CAS
- 69304-49-0
- Formula
- C6H5BrN2O2
- MW
- 217.02 g/mol
VQ-024658
![(E)-5-(3-(Dimethylamino)propylidene)-10,11-dihydro-5H-dibenzo[a,d][7]annulen-10-ol chemical structure](/media/structures/GHWBJXOKAFHZAI-SFQUDFHCSA-N.svg)
(E)-5-(3-(Dimethylamino)propylidene)-10,11-dihydro-5H-dibenzo[a,d][7]annulen-10-ol
- CAS
- 64520-05-4
- Formula
- C20H23NO
- MW
- 293.4 g/mol
VQ-029124
(E)-6-Iodo-3-(2-(pyridin-2-yl)vinyl)-1H-indazole
- CAS
- 1952288-48-0
- Formula
- C14H10IN3
- MW
- 347.15 g/mol
VQ-035876
![(E)-6-Iodo-3-[2-(pyridin-2-yl)ethenyl]-1-(tetrahydro-2H-pyran-2-yl)-1H-indazole chemical structure](/media/structures/QXJFRDDGGSSQDX-CSKARUKUSA-N.svg)
(E)-6-Iodo-3-[2-(pyridin-2-yl)ethenyl]-1-(tetrahydro-2H-pyran-2-yl)-1H-indazole
- CAS
- 886230-77-9
- Formula
- C19H18IN3O
- MW
- 431.3 g/mol
VQ-021689
(E)-7-(2-Cyclopropyl-4-(4-fluorophenyl)quinolin-3-yl)-3-hydroxy-5-oxohept-6-enoic acid
- CAS
- 1809100-36-4
- Formula
- C25H22FNO4
- MW
- 419.4 g/mol
VQ-033230
![(E)-7-Acetyl-6-(2-formamidovinyl)-4-methylbenzo[d][1,3]dioxol-5-yl acetate chemical structure](/media/structures/JQRCKPWOPOQUNP-SNAWJCMRSA-N.svg)
(E)-7-Acetyl-6-(2-formamidovinyl)-4-methylbenzo[d][1,3]dioxol-5-yl acetate
- CAS
- 250159-76-3
- Formula
- C15H15NO6
- MW
- 305.28 g/mol
VQ-034376
(E)-8-(3,4-Dimethoxystyryl)-1,3-diethyl-9-methyl-3,9-dihydro-1H-purine-2,6-dione
- CAS
- 1453190-01-6
- Formula
- C20H24N4O4
- MW
- 384.4 g/mol
VQ-031302
(E)-8-(3,4-Dimethoxystyryl)-1,3-diethylxanthine
- CAS
- 155270-98-7
- Formula
- C19H22N4O4
- MW
- 370.4 g/mol
VQ-022882
![(E)-8-Ethyl-5,6,8,11,12,13,14,15,16,17,18,19,24,25,26,26a-hexadecahydro-5,19-dihydroxy-3-[(E)-2-(4-hydroxy-3-methoxycyclohexyl)-1-methylvinyl]-14,16-dimethoxy-4,10,12,18-tetramethyl-15,19-epoxy-3H-pyrido[2,1-c][1,4]oxaazacyclotricosine-1,7,20,21-(4H,23H)-tetrone chemical structure](/media/structures/ZDQSOHOQTUFQEM-NURRSENYSA-N.svg)
(E)-8-Ethyl-5,6,8,11,12,13,14,15,16,17,18,19,24,25,26,26a-hexadecahydro-5,19-dihydroxy-3-[(E)-2-(4-hydroxy-3-methoxycyclohexyl)-1-methylvinyl]-14,16-dimethoxy-4,10,12,18-tetramethyl-15,19-epoxy-3H-pyrido[2,1-c][1,4]oxaazacyclotricosine-1,7,20,21-(4H,23H)-tetrone
- CAS
- 135635-46-0
- Formula
- C43H69NO12
- MW
- 792 g/mol
VQ-034012
Need a price, a spec or a custom compound?
Send us your list — product names or CAS numbers, grade, quantity and destination. Our team replies with a formal quotation, COA and lead time.